# Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung

> **NCT00902707** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 12 (actual)

## Conditions studied

- Mucociliary Clearance

## Interventions

- **DRUG:** Mucinex 1200mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00902707
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902707, "Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00902707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*